50. FARID FOROUTAN
Information acquired: 2025
FARID FOROUTAN is an academic who published a paper in 2021 entitled Antibody and cellular therapies for treatment of covid-19 : a living systematic review and network m. FARID FOROUTAN published this work as part of a team: Siemieniuk, Reed A. C.. Here is a description of this work: OBJECTIVE To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19). DESIGN Living systematic review and network meta-analysis, with pairwise meta-analysis for outcomes with insufficient data. DATA SOURCES WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature, and six Chinese databases (up to 21 July 2021). STUDY SELECTION Trials randomising people with suspected, probable, or confirmed covid-19 to antiviral antibody therapies, blood products, or standard care or placebo. Paired reviewers determined eligibility of trials independently and in duplicate. METHODS After duplicate data abstraction, we performed random effects bayesian meta-analysis, including network meta-analysis for outcomes with sufficient.